VJHemOnc is committed to improving our service to you

EBMT 2020 | Horizon scan of CAR-T in multiple myeloma

VJHemOnc is committed to improving our service to you

Michel Delforge

Michel Delforge, MD, PhD, University of Leuven, Leuven, Belgium, provides a horizon scan of the field of CAR T-cell therapies in the treatment and manangment of multiple myeloma, including the liscencing of CAR-T therapies in Europe and the use of CAR-T in earlier settings as well as identifying patients that will likely respond well to CAR T-cell therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter